Trial Profile
Prospective, randomized, open-label trial of anti hypertensive therapies in combination with high dose Amlodipine/Irbesartan vs. triple combination with Amlodipine/Irbesartan/Indapamide (Asahi Ai Study)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Jul 2018
Price :
$35
*
At a glance
- Drugs Amlodipine/irbesartan (Primary) ; Amlodipine; Indapamide
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms Asahi-Ai
- 28 Jul 2018 New trial record
- 11 Jun 2018 Results presented at the 28th European Meeting on Hypertension and Cardiovascular Protection